Tapentadol: all 60 studies that test it

Page 1 of 1. Open to participants first (1), then studies with results posted, then the rest; newest registration first within each.

• Tapentadol vs Tramadol in Total Knee ArthroplastyRecruitingNCT06269770Phase 4
• Use of Tapentadol Oral Solution for Pain After Surgery in Children From Newborn to Less Than 2 Years OldTerminatedNCT02221674Phase 2Results posted
• A Study to Look at Tapentadol Tablets in Children and Adolescents in PainCompletedNCT02151682Phase 2/3Results posted
• A Study to Look at Tapentadol Oral Solution in Children and Adolescents in PainCompletedNCT02081391Phase 3Results posted
• Tapentadol Prolonged Release (PR) Versus Oxycodone/Naloxone Prolonged Release in Severe Chronic Low Back Pain With a Neuropathic Component.CompletedNCT01838616Phase 4Results posted
• A Study to Evaluate the Effectiveness and Safety of Tapentadol (CG5503) in the Treatment of Acute Pain From Bunionectomy Compared With PlaceboCompletedNCT01813890Phase 3Results posted
• Pharmacokinetic, Efficacy and Safety Study of Tapentadol Oral Solution in Children With Postoperative PainCompletedNCT01729728Phase 2Results posted
• A Study of Tapentadol Immediate-Release in the Treatment of Patients With Acute Pain From BunionectomyCompletedNCT01516008Phase 3Results posted
• Comparison of the Effects of Tapentadol and Oxycodone on Gastrointestinal and Colonic Transit in HumansCompletedNCT01500317Phase 4Results posted
• Tapentadol Versus Oxycodone - a Mechanism-based Treatment Approach in Neuropathic PainTerminatedNCT01458015Phase 4Results posted
• Intravenous Tapentadol in Post-Bunionectomy PainCompletedNCT01435577Phase 2Results posted
• Comparison of Increasing Doses of Tapentadol Versus a Combination of Tapentadol and PregabalinCompletedNCT01352741Phase 4Results posted
• A Safety and Efficacy Study of Oral Tapentadol Extended-Release in Japanese ParticipantsCompletedNCT01309386Phase 3Results posted
• Tapentadol in Chronic Malignant Tumour Related PainTerminatedNCT01264887Phase 3Results posted
• A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer PainCompletedNCT01165281Phase 3Results posted
• A Phase 2 Study of Tapentadol Extended-Release (JNS024ER) ) in Japanese Participants With Chronic Pain Due to Diabetic Neuropathic Pain or Postherpetic NeuralgiaCompletedNCT01124617Phase 2Results posted
• An Efficacy and Safety Study for Tapentadol Extended Release (JNS024ER) in Chronic Pain ParticipantsCompletedNCT01124604Phase 2Results posted
• A Long-term Safety Study With Tapentadol ER and Oxycodone CR in Patients With Moderate to Severe Pain Due to Chronic, Painful Diabetic Peripheral Neuropathy (DPN)TerminatedNCT01063868Phase 3Results posted
• A Study to Evaluate the Efficacy, Safety, and Tolerability of Tapentadol ER Compared With Placebo in Patients With Chronic, Painful Diabetic Peripheral NeuropathyCompletedNCT01041859Phase 3Results posted
• Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Chronic Low Back Pain Taking WHO Step III Analgesics But Showing a Lack of TolerabilityTerminatedNCT00986258Phase 3Results posted
• NUCYNTA (Tapentadol Immediate Release) Versus Oxycodone Immediate Release in the Treatment of Acute Low Back PainCompletedNCT00986180Phase 3Results posted
• Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Chronic Low Back Pain Taking Either WHO Step I or Step II Analgesics or no Regular AnalgesicsCompletedNCT00983385Phase 3Results posted
• Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Pain Due to Osteoarthritis Taking Either WHO Step I or Step II Analgesics or no Regular AnalgesicCompletedNCT00983073Phase 3Results posted
• Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Pain Due to Osteoarthritis Taking WHO Step III Analgesics But Showing a Lack of Tolerability.TerminatedNCT00982280Phase 3Results posted
• Safety and Efficacy of Tapentadol Immediate Release (IR) and Oxycodone IR for Treatment of Acute Post-op Pain Following Elective Arthroscopic (Surgery Using a Thin Flexible Scope) Shoulder SurgeryCompletedNCT00814580Phase 3Results posted
• A Study to Compare the Frequency of Constipation Symptoms With Tapentadol Immediate Release (IR) Treatment Versus Oxycodone IR Treatment in Patients With End-stage Joint DiseaseCompletedNCT00784277Phase 3Results posted
• Tapentadol IR vs Oxycodone IR vs Placebo in Acute Pain From Vertebral Compression Fracture Associated With OsteoporosisCompletedNCT00771758Phase 3Results posted
• A Study to Evaluate the Effectiveness and Safety of Tapentadol (CG5503) in the Treatment of Acute Pain From Bunionectomy.CompletedNCT00613938Phase 3Results posted
• A Trial to Evaluate CG5503 Efficacy and Safety in Acute Pain After BunionectomyCompletedNCT00609466Phase 3Results posted
• Study on the Safety and Effectiveness of Switching Between Two Forms of Tapentadol in Patients With Chronic Low Back PainCompletedNCT00594516Phase 3Results posted
• A Study to Evaluate the Effectiveness and Safety of CG5503 (Tapentadol) in the Treatment of Chronic Tumor Related Pain Compared With Placebo and MorphineTerminatedNCT00505414Phase 3Results posted
• An Open-label Extension Study With Flexible Dosing of Extended-release (ER) Tapentadol (CG5503) to Treat Patients With Moderate to Severe Chronic PainCompletedNCT00487435Phase 3Results posted
• A Study to Evaluate the Efficacy and Safety of CG5503 Prolonged Release (PR) in Subjects With Moderate to Severe Chronic Pain Due to Osteoarthritis of the KneeCompletedNCT00486811Phase 3Results posted
• A Study to Evaluate the Efficacy and Safety of Tapentadol (CG5503) in the Treatment of Acute Pain After Abdominal HysterectomyCompletedNCT00478023Phase 3Results posted
• A Study to Evaluate Tapentadol (CG5503) in the Treatment of Chronic Tumor-Related Pain Compared With Placebo and MorphineCompletedNCT00472303Phase 3Results posted
• A Safety and Efficacy Study for Tapentadol (CG5503) Extended Release for Patients With Painful Diabetic Peripheral NeuropathyCompletedNCT00455520Phase 3Results posted
• A Study to Evaluate the Effectiveness and Safety of Tapentadol (CG5503) Extended Release (ER) in Patients With Moderate to Severe Chronic Low Back PainCompletedNCT00449176Phase 3Results posted
• Tapentadol (CG5503)CompletedNCT00421928Phase 3Results posted
• A Study to Evaluate the Effectiveness and Safety of Tapentadol(CG5503) in the Treatment of Acute Pain After Hip Replacement Surgery Compared With Oxycodone and Placebo Followed by a Voluntary Open-Label Extension For SafetyTerminatedNCT00364533Phase 3Results posted
• A Study to Evaluate Long-Term Safety of Multiple Doses of Tapentadol (CG5503) Prolonged-Release (PR) and Oxycodone Controlled-Release (CR) in Patients With Chronic PainCompletedNCT00361504Phase 3Results posted
• Tapentadol vs Pregabalin for Postoperative Pain in Lower Limb SurgeryCompletedNCT07587645Not applicable
• Role of Preoperative Tapentadol in Reduction of Perioperative Analgesic Requirement After Breast Conservative Surgery in Cancer Patients.CompletedNCT07320781Not applicable
• Comparison of Postoperative Analgesia Between Intravenous Paracetamol and Intranasal TapentadolCompletedNCT05999890Phase 4
• Effect of a Multiple-dose Oral Administration of CG5503 PR on the Electrical Activity of the Heart in 48 Healthy Men and WomenCompletedNCT03951402Phase 1
• Safety and Efficacy of Pre-emptive Tapentadol vs Pregabalin in Post Operative Pain Following SurgeryCompletedNCT03604354Phase 4
• Preemptive Tapentadol on Post-operative Analgesia Following Total Knee ArthroplastyCompletedNCT03351517Not applicable
• Effects of Tapentadol Versus Oxycodone After Hysterectomy.CompletedNCT03314792Phase 4
• Opioid Induced Gait VariabilityCompletedNCT03121547Phase 1/2
• Depot-opioids for Pre- and Postoperative Pain Relief After Primary Knee Arthroplasty.Tapentadol vs Oxycodone vs PlaceboCompletedNCT02604446Phase 3
• Phase 1 Pharmacokinetic Study of Tapentadol Prolonged-Release 250 Milligram (mg) Formulation in Healthy ParticipantsCompletedNCT01877226Phase 1
• An Open-label Evaluation of Tapentadol Extended Release (ER) in Participants With Moderate to Severe Chronic Pain After Conversion From Hydrocodone, Oxycodone Controlled Release (CR), and/or Morphine Sustained Release (SR)WithdrawnNCT01631513Phase 4
• A Study to Compare the Dose-proportionality of Tapentadol (CG5503) in Healthy Japanese and Korean Male VolunteersCompletedNCT01309425Phase 1
• A Study to Compare the Bioequivalence of 50-mg Tapentadol (CG5503) Dose Administered as Two 50-mg Tablets Relative to One 100-mg TabletCompletedNCT01273532Phase 1
• A Study to Compare the Bioequivalence of 50-mg Tapentadol (CG5503) Dose Administered as Two 25-mg Tablets Relative to One 50-mg TabletCompletedNCT01273506Phase 1
• Pharmacokinetics and Safety Study of Tapentadol for Postsurgical Pain in Children and AdolescentsCompletedNCT01134536Phase 2
• A Randomized, Double-Blind, Parallel-Arm, Placebo and Active Controlled Dose-Ranging Study of the Efficacy and Safety of Multiple Doses of Tapentadol IR for Postoperative Pain Following Bunionectomy SurgeryCompletedNCT00806247Phase 2
• Efficacy and Safety of Tapentadol Extended Release Tablets in the Treatment of Moderate to Severe Pain in Subjects With Knee OsteoarthritisCompletedNCT00745069Phase 2
• A Study to Evaluate 90-Day Safety of Tapentadol(CG5503) Immediate Release (IR) or Oxycodone Immediate Release in Patients With Chronic PainCompletedNCT00364546Phase 3
• A Study to Evaluate the Effectiveness and Safety of Tapentadol(CG5503) in the Treatment of Acute Pain From Bunionectomy Compared With Placebo Followed by a Voluntary Open Label Extension for Safety.CompletedNCT00364247Phase 3
• A Study to Evaluate the Effectiveness and Safety of Multiple Doses of Tapentadol(CG5503) in Patients Awaiting Joint Replacement SurgeryCompletedNCT00361582Phase 3

← Tapentadol overview